SeaStar Medical Holding (ICU) has provided an update.
SeaStar Medical Holding Corporation has announced the appointment of John Neuman, a seasoned financial expert with a 30-year tenure at Dow Chemical Company, as a Class I director following the resignation of Andres Lobo. Neuman, who has significant experience in global financial accounting and has been instrumental in major M&A transactions, will bring his expertise to SeaStar’s board. Alongside Neuman, two other members, Jennifer A. Baird and Bernadette N. Vincent, have been elected to the board, as detailed in a recent press release by the Company.
For an in-depth examination of ICU stock, go to TipRanks’ Stock Analysis page.
